MYC deregulation in gastric cancer and its clinicopathological implications.
about
Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsThe role of piRNA and its potential clinical implications in cancerEvaluation of the use of therapeutic peptides for cancer treatmentEpigenetics: an emerging player in gastric cancerSubtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancerCopy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-TypeDeregulated Expression of SRC, LYN and CKB Kinases by DNA Methylation and Its Potential Role in Gastric Cancer Invasiveness and MetastasisStudy of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods.What gastric cancer proteomic studies show about gastric carcinogenesis?BET inhibition as a new strategy for the treatment of gastric cancer.Combining multi-dimensional data to identify key genes and pathways in gastric cancerAssociation Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer.Effect of Helicobacter pylori on NFKB1, p38α and TNF-α mRNA expression levels in human gastric mucosaIdentification of IL11RA and MELK amplification in gastric cancer by comprehensive genomic profiling of gastric cancer cell lines.Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications.YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A.miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results.Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells.Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas.Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.Gastric Cancer Cell Lines Have Different -Regulated Expression Patterns but Share a Common Core of Altered GenesDysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
P2860
Q27012898-B3C18C0C-83E7-4B6B-9106-0CF9D6F9C65FQ28083603-1094A710-E179-4143-9A8A-59BE4DCC6E6FQ29048586-B683700F-1FFD-4765-8FD4-2366EDACE257Q33718259-695A5FA8-D35D-4EAC-B3C7-BDFF21CA659BQ35000289-A38B1C5B-57EC-4FD3-9665-501B1E7B9821Q35740107-BF7CDCD2-B777-41C0-9A84-81273BF979F8Q35770650-A6749564-054A-4081-8A40-8178E6270160Q35804400-A72760BE-5D29-458A-919F-691DAC765356Q35884433-6682E86D-079A-40A5-A157-54C4F3FBE0D7Q36002404-029A2DF7-CD2A-4535-8C93-36F457B41AC9Q36040347-84864424-4435-4A74-ACA4-B525AE40A4D8Q36398831-A085D68F-87E6-428E-92AA-AD11270F094CQ36890084-562774AF-134A-4E03-A218-7C0493F13E30Q36953314-3EE0C564-C233-4026-A9A5-502EAF2AAC23Q37424716-3F7F8261-D619-457E-8A5A-000A1E86A0DDQ37485790-2B49646E-0206-478E-8956-5F97D48349B5Q37709154-9B737129-D8BD-4AE0-885C-3599CBBF2CBCQ37747326-766C5024-9E8E-4C6E-A514-704FF073BDA5Q38527414-63B4D585-057D-4610-A1C5-4B57624CEC9AQ39011776-E5AFD318-7F3B-41D0-92ED-5226E2720505Q39017073-43086DB3-53BF-493C-82A1-F7D92CD010E0Q40309206-45E9B826-E539-44B2-8F7D-B707F35329AAQ47135988-21535F34-AEE1-46BE-A77A-2A4AF02DBE12Q47786705-E0A43D1A-C859-4BE5-88E0-00E538B2AB7EQ53210821-BB55EAF1-47DE-4858-A96E-4F1E4488510DQ53636235-1B862BF1-E9C6-4EDB-AB1A-20FA63D5F26AQ55423483-F87CD61E-FBE2-49D4-9F64-D497A90EE8E1Q58551710-EE96C6A4-C92C-49C9-B668-67A7E30FFB0FQ58613516-09D96D3C-A7BC-4038-93A3-60F1E9B44B0E
P2860
MYC deregulation in gastric cancer and its clinicopathological implications.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MYC deregulation in gastric cancer and its clinicopathological implications.
@ast
MYC deregulation in gastric cancer and its clinicopathological implications.
@en
MYC deregulation in gastric cancer and its clinicopathological implications.
@nl
type
label
MYC deregulation in gastric cancer and its clinicopathological implications.
@ast
MYC deregulation in gastric cancer and its clinicopathological implications.
@en
MYC deregulation in gastric cancer and its clinicopathological implications.
@nl
prefLabel
MYC deregulation in gastric cancer and its clinicopathological implications.
@ast
MYC deregulation in gastric cancer and its clinicopathological implications.
@en
MYC deregulation in gastric cancer and its clinicopathological implications.
@nl
P2093
P2860
P1433
P1476
MYC deregulation in gastric cancer and its clinicopathological implications
@en
P2093
Andrea Kely Campos Ribeiro Dos Santos
Carolina Rosal Teixeira de Souza
Danielle Queiroz Calcagno
Eliana Kelly Costa Sozinho
Helem Ferreira Ribeiro
Marília de Arruda Cardoso Smith
Paulo Pimentel Assumpção
Raquel Carvalho Montenegro
Rommel Rodríguez Burbano
Sidney Emanuel Batista Dos Santos
P2860
P304
P356
10.1371/JOURNAL.PONE.0064420
P407
P577
2013-05-22T00:00:00Z